Literature DB >> 2585234

Outcome of pectus excavatum in patients with Marfan syndrome and in the general population.

P H Arn1, L R Scherer, J A Haller, R E Pyeritz.   

Abstract

We reviewed the records of 28 patients with Marfan syndrome and 30 age-matched control patients with presumed isolated pectus excavatum to determine the outcome of surgical repair of the pectus deformity in Marfan syndrome. One third of the patients with Marfan syndrome underwent repair of the pectus excavatum before diagnosis. Of the 30 patients with "isolated" pectus excavatum, 17 had findings by history or physical examination, such as mitral valve prolapse, scoliosis, or a relative with pectus excavatum, suggestive of an underlying disorder of connective tissue. Pectus excavatum of more than moderate severity recurred in 11 of 28 patients with Marfan syndrome and was associated with young age at initial surgery and lack of temporary internal stabilization of the chest after surgery. Only two of the control patients had recurrence of the defect; one of these patients had findings suggestive of an underlying heritable disorder of connective tissue. We conclude that pectus excavatum may indicate the presence of an underlying heritable disorder of connective tissue such as the Marfan syndrome. In patients with Marfan syndrome, and possibly other inherited connective tissue disorders, surgical repair should be delayed if possible until skeletal maturity is nearly complete and should employ internal stabilization.

Entities:  

Mesh:

Year:  1989        PMID: 2585234     DOI: 10.1016/s0022-3476(89)80749-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 2.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

Review 3.  A Review of Psychosocial Factors of Marfan Syndrome: Adolescents, Adults, Families, and Providers.

Authors:  Cory Nielsen; Ileana Ratiu; Mitra Esfandiarei; Angela Chen; Elif Seda Selamet Tierney
Journal:  J Pediatr Genet       Date:  2019-07-25

4.  Combined Bentall and modified Ravitch procedures in a patient with Marfan syndrome.

Authors:  Bhuvnesh Kansara; Ajmer Singh; Samir Girotra; K S Iyer
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01

5.  Modified Nuss procedure is a safe choice for recurrent pectus excavatum after previous open repair experience of 26 cases.

Authors:  Liang Hai Long; Liu Ji Fu; Zhao Jing; Zhang Wei Qiang
Journal:  Pediatr Surg Int       Date:  2013-04-16       Impact factor: 1.827

Review 6.  Parsonage-Turner Syndrome and Closed-Incision Negative-Pressure Wound Therapy After Total Hip Arthroplasty in a Case of Marfan Syndrome.

Authors:  Seyed Mohammad Javad Mortazavi; Mohammadreza Razzaghof; Mohammad Ali Ghasemi
Journal:  Arthroplast Today       Date:  2022-01-20

Review 7.  The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management.

Authors:  Lily Pollock; Ashley Ridout; James Teh; Colin Nnadi; Dionisios Stavroulias; Alex Pitcher; Edward Blair; Paul Wordsworth; Tonia L Vincent
Journal:  Curr Rheumatol Rep       Date:  2021-11-26       Impact factor: 4.592

Review 8.  Pectus excavatum and heritable disorders of the connective tissue.

Authors:  Francesca Tocchioni; Marco Ghionzoli; Antonio Messineo; Paolo Romagnoli
Journal:  Pediatr Rep       Date:  2013-09-24

9.  Pectus updates and special considerations in Marfan syndrome.

Authors:  Stephanie Fraser; Anne Child; Ian Hunt
Journal:  Pediatr Rep       Date:  2018-01-04

10.  Increased visceral arterial tortuosity in Marfan syndrome.

Authors:  Bence Ágg; Bálint Szilveszter; Noémi Daradics; Kálmán Benke; Roland Stengl; Márton Kolossváry; Miklós Pólos; Tamás Radovits; Péter Ferdinandy; Béla Merkely; Pál Maurovich-Horvat; Zoltán Szabolcs
Journal:  Orphanet J Rare Dis       Date:  2020-04-15       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.